Target intelligence / Profile preview

Leucine-rich repeat and IQ motif-containing protein 3 (LRRIQ3)

Target
LRRIQ3
Molecular classification
Other (contains leucine-rich repeats and an IQ calmodulin-binding motif, not a receptor, enzyme, transporter, channel, or transcription factor)
01

Overview

Leucine-rich repeat and IQ motif-containing protein 3 (LRRIQ3) is a protein-coding gene that encodes a membrane-associated protein featuring three leucine-rich repeats and a single IQ calmodulin-binding motif. The protein is expressed at low to moderate levels in human tissues, with highest expression in the testes, some immune cells, kidney, glands, and epididymis. LRRIQ3 is involved in protein-protein interactions with molecules such as LYN, NCK2, GNB4, and ABL1, all of which are linked to signaling and cytoskeleton regulation. Genome-wide association studies implicate genetic variation in LRRIQ3 in susceptibility to chronic pain and major depressive disorder. Its transcript levels have been proposed as part of a predictive gene signature for rectal cancer response to chemoradiotherapy, and its downregulation has been observed in several cancer types, supporting its role as a novel biomarker for both neuropsychiatric and oncological contexts. No validated drugs or direct therapeutic targeting information is currently available.

Other names
LRRC44leucine-rich repeats and IQ motif containing 3leucine rich repeats and IQ motif containing 3leucine-rich repeat-containing protein 44MGC22773
02

Biological functions

Protein bindingPotential involvement in cell signaling, cytoskeletal reorganization, and cell differentiation via protein-protein interactions
03

Disease associations

Cancer (downregulated in pancreatic, colorectal, and breast cancer)Neuropsychiatric disorders (variants associated with major depressive disorder and chronic pain)
04

Biomarkers

Biomarker for response to neoadjuvant chemoradiotherapy in rectal cancer

Beyond the preview

Go deeper on Leucine-rich repeat and IQ motif-containing protein 3 (LRRIQ3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat and IQ motif-containing protein 3 (LRRIQ3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call